Home » Products » Pharma Medicine » Eurepa-1 (Repaglinide Tablets I.P)

Eurepa-1 (Repaglinide Tablets I.P)

Eurepa-1 (Repaglinide Tablets I.P)
Eurepa-1 (Repaglinide Tablets I.P)
Send Inquiry
Product Code : 541
Brand Name : Eurepa-1
Price And Quantity
  • Minimum Order Quantity
  • 10000000
  • Unit of Measure
  • Piece/Pieces
  • Price
  • 145 INR
Product Specifications
  • Drug Type
  • Specific Drug
  • Physical Form
  • Tablets
  • Dosage
  • 1 mg
  • Suitable For
  • Adults, Women
Product Description
EUREPA 1MG TABLET Torrent Pharmaceuticals Ltd : COMPOSITION FOR EUREPA 1MG TABLETRepaglinide(1mg)

FOOD INTERACTION FOR EUREPA TABLET :It is better to take Eurepa 1mg tablet empty stomach (1 hour before food or 2 hours after food).SALT INFORMATION FOR EUREPA 1MG TABLETRepaglinide(1mg)Eurepa tablet uses : Eurepa 1mg tablet is used in the treatment of type 2 diabetes

How eurepa tablet works : Eurepa 1mg tablet increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels.
Common side effects of eurepa tablet : Hypoglycemia (Low blood sugar level), Abdominal pain, Diarrhoea

ALCOHOL INTERACTION FOR EUREPA TABLET : Taking repaglinide with alcohol may affect blood glucose levels in patients with diabetes.UNSAFE

PREGNANCY INTERACTION FOR EUREPA TABLET : Eurepa 1mg tablet may be unsafe to use during pregnancy.Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.WEIGH RISKS VS. BENEFITS

LACTATION INTERACTION FOR EUREPA TABLET : Unknown. Human and animal studies are not available. Please consult your doctor.
Trade Information
  • Payment Terms
  • Cash Advance (CA), Cash in Advance (CID)
  • Supply Ability
  • 10000000 Per Week
  • Delivery Time
  • 1 Week
  • Main Export Market(s)
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa


Developed and Managed by Infocom Network Ltd.